Epitope's OraSure set for October launch
This article was originally published in Clinica
SmithKline Beecham is set to launch Epitope's OraSure, the oral specimen collection device, in selected US markets next month. SKB says further US distribution will occur once Epitope receives FDA approval of its OraSure Western blot confirmatory test. OraSure is already approved for HIV antibody screening.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.